Ferguson Wellman Capital Management Inc. boosted its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 898,200 shares of the company’s stock after purchasing an additional 6,874 shares during the quarter. Procter & Gamble makes up 2.2% of Ferguson Wellman Capital Management Inc.’s portfolio, making the stock its 9th biggest holding. Ferguson Wellman Capital Management Inc.’s holdings in Procter & Gamble were worth $138,008,000 at the end of the most recent quarter.
A number of other hedge funds have also made changes to their positions in PG. Vanguard Group Inc. grew its stake in Procter & Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock valued at $37,155,222,000 after acquiring an additional 3,189,111 shares during the last quarter. Kingstone Capital Partners Texas LLC lifted its holdings in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Procter & Gamble by 1.8% in the second quarter. Geode Capital Management LLC now owns 59,415,933 shares of the company’s stock valued at $9,439,341,000 after purchasing an additional 1,060,713 shares during the last quarter. Norges Bank purchased a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $5,099,644,000. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Procter & Gamble by 1.7% during the 2nd quarter. Charles Schwab Investment Management Inc. now owns 17,385,571 shares of the company’s stock worth $2,770,035,000 after purchasing an additional 294,673 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Up 2.6%
NYSE PG opened at $141.57 on Friday. The company has a market cap of $330.81 billion, a P/E ratio of 20.67, a P/E/G ratio of 4.65 and a beta of 0.39. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $179.99. The company has a debt-to-equity ratio of 0.46, a current ratio of 0.71 and a quick ratio of 0.51. The company has a 50-day moving average of $145.11 and a 200-day moving average of $151.70.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio is presently 61.75%.
Insider Buying and Selling at Procter & Gamble
In related news, CAO Matthew W. Janzaruk sold 725 shares of Procter & Gamble stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $149.57, for a total value of $108,438.25. Following the transaction, the chief accounting officer owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.20% of the company’s stock.
Analysts Set New Price Targets
A number of brokerages have commented on PG. JPMorgan Chase & Co. lowered their target price on Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating on the stock in a report on Thursday, December 18th. Deutsche Bank Aktiengesellschaft decreased their price objective on Procter & Gamble from $176.00 to $171.00 and set a “buy” rating on the stock in a research note on Monday, December 8th. Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research note on Monday, October 27th. BNP Paribas Exane lowered their price target on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a report on Tuesday, September 23rd. Finally, Jefferies Financial Group raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their price objective for the company from $156.00 to $179.00 in a research report on Tuesday, December 16th. Fifteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $169.23.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst and industry pieces highlighting PG’s pricing power and defensive cash flows support the long-term investment case and dividend thesis, providing upside support. 5 Under-the-Radar Consumer Staples Stocks With Pricing Power (PG)
- Positive Sentiment: Articles arguing that focused execution and margin discipline make PG attractive keep buy-side interest alive despite recent weakness. Procter & Gamble: Intense Focus Makes It Attractive
- Positive Sentiment: Inclusion on dividend-stock roundups emphasizes PG’s reliable payout and may attract income-focused buyers. 3 Dividend Stocks to Buy and Forget About
- Positive Sentiment: Additional dividend-focused coverage reinforces yield-focused demand for the shares. 3 Dividend Stocks to Double Up On Right Now
- Neutral Sentiment: PG agreed to change Crest children’s toothpaste packaging and marketing to address concerns raised by the Texas Attorney General—this reduces regulatory/legal tail risk but is not expected to materially affect core sales. Procter & Gamble changes Crest toothpaste packaging to address Texas AG fluoride concerns
- Neutral Sentiment: Preview/valuation pieces and calls ahead of the upcoming leadership/earnings cadence keep the name on investors’ watchlists but don’t change fundamentals immediately. Procter & Gamble (PG) Valuation Check As First Jejurikar Earnings Call Approaches
- Negative Sentiment: Wells Fargo lowered its price target on PG to $158 from $170 while keeping an Overweight rating—this reduces near-term upside expectations and likely weighed on sentiment. Wells Fargo Trims Procter & Gamble (PG) Target as 2026 Models Reset
- Negative Sentiment: TD Cowen lowered its target to $150 (while keeping a Buy), signaling analysts are resetting 2026 models and trimming expectations for growth and margin recovery. Benzinga – TD Cowen price target cut
- Negative Sentiment: Shares recently touched a 52-week low amid soft category demand and promotional pressure—this is the core driver of the recent downtrend and investor caution. Procter & Gamble Hits 52-Week Low: Buy Opportunity or Warning Sign?
- Negative Sentiment: Coverage noting an extended losing streak and peer-focused analyst caution adds to near-term selling pressure. Procter & Gamble extends losing streak for seventh straight session
Procter & Gamble Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
- Five stocks we like better than Procter & Gamble
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- First Time Since 2007: All Warnings Active
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
